Great Valley Advisor Group Inc. Increases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Great Valley Advisor Group Inc. raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,414 shares of the exchange traded fund’s stock after purchasing an additional 746 shares during the period. Great Valley Advisor Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $337,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Hartline Investment Corp increased its stake in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after purchasing an additional 106 shares during the last quarter. Intellectus Partners LLC grew its position in shares of SPDR S&P Biotech ETF by 1.0% during the second quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock worth $1,051,000 after acquiring an additional 113 shares during the last quarter. Signature Estate & Investment Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 5.7% during the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after acquiring an additional 125 shares during the last quarter. Denver Wealth Management Inc. grew its position in shares of SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after acquiring an additional 127 shares during the last quarter. Finally, Bourgeon Capital Management LLC grew its position in shares of SPDR S&P Biotech ETF by 5.9% during the second quarter. Bourgeon Capital Management LLC now owns 2,427 shares of the exchange traded fund’s stock worth $225,000 after acquiring an additional 135 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.2 %

Shares of XBI opened at $100.00 on Thursday. The firm has a market cap of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s 50 day simple moving average is $98.33 and its 200-day simple moving average is $96.46. SPDR S&P Biotech ETF has a 12-month low of $72.10 and a 12-month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.